Anti-BMI-1 Antibody, clone F6 ZooMAb^® Mouse Monoclonal

200

mouse (recombinant)

expressed in HEK 293 cells

unconjugated

purified antibody

primary antibodies

F6, monoclonal
recombinant monoclonal

ZooMAb^® learn more

lyophilized

calculated mol wt 36.95 kDa
observed mol wt ~38 kDa

human, mouse

rabbit, rat

antibody small pack of 25 μL

Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

recombinant expression
Learn more about Antibody Enhanced Validation

immunocytochemistry: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
western blot: suitable

IgG1

Aligned

ambient

2-8℃

ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.

Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.

Learn more about ZooMAb here.

Clone F6 is a ZooMAb mouse recombinant monoclonal antibody that specifically detects BMI-I. It targets an epitope within the N-terminal region.

Recombinant fragment corresponding to the first 202 amino acids from Mouse Polycomb complex protein BMI-1.

Anti-BMI-1, clone F6 ZooMAb, Cat. No. ZMS05637, is a recombinant mouse monoclonal antibody that specifically targets BMI-1 and is tested for use in Immunocytochemistry, Immunohistochemistry (Paraffin), and Western Blotting.
Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected BMI-1 in U2OS cell lysate.

Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected BMI-1 in human placenta tissue sections.

Immunocytochemistry Analysis: A 1:1,000 dilution from a representative lot detected BMI-1 in HeLa, A431, HUVEC and NIH 3T3 cells.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user

Purified recombinant mouse monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

0.3 mg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Polycomb complex protein BMI-1 (UniProt: P35226; also known as Polycomb group RING finger protein 4, RING finger protein 51) is encoded by the BMI1 (also known as PCGF4, RNF51) gene (Gene ID: 100532731) in human. BMI-I (B cell-specific Moloney murine leukemia virus integration site 1) is a component of the polycomb repressive complex 1 (PRC1) that is required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. This complex acts via chromatin remodeling and modification of histones and mediates mono-ubiquitination of histone H2A lysine 119, rendering chromatin. The canonical PRC1 complex consists of four core subunits: CBX (polycomb; CBX2/4/6/7/8), PCGF (polycomb group factors; PCGF1 6), PHC (polyhomeotic homologues; PHC1/2/3), and RING E3 ligase (RING1A/B). BMI-I has three domains. The N-terminal RING domain, a central domain, and a C-terminal proline-rich domain. The RING domain forms a complex with RINGA/B proteins that constitutes the heterodimeric E3 ubiquitin ligase subunit of the PRC1 complex. The central is a ubiquitin-like (UBL) domain and is involved in protein-protein interactions and its binding partners include the polyhomeotic proteins (PHC1, PHC2, PHC3). The central domain of BMI-I is reported to be essential for its oncogenic activity and is shown to be essential for transcriptional repression activity. Higher expression of BMI1 gene is overexpressed in certain mantle cell lymphomas and several other cancers. This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Gray, F., et al. (2016). Nat. Commun. 7; 13343).

Recommend storage of lyophilized product at 2-8℃; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8℃, or -20℃ for long term storage. Avoid repeated freeze-thaws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

11 - Combustible Solids

WGK 1